Indications and uses
Relieves diarrhea, reduces number of bowel movements. Helps firm stool. Relieves nausea, heartburn, fullness due to overindulgence of food and drink.
Relieves diarrhea, reduces number of bowel movements. Helps firm stool. Relieves nausea, heartburn, fullness due to overindulgence of food and drink.
(shake well before using) Adults and children 12 yrs and over : 2 teaspoonfuls every hour as needed , not to exceed 4 doses in 24 hours and not more than 2 days. Children under 12: Consult a doctor.
Active Ingredients
Bismuth Subsalicylate
Antidiarrheal
Children and teenagers that have or are recovering from Chicken Pox, flu systems, or flue should NOT use this product. If nausea, vomiting, or fever occur, consult a doctor because these symptoms could be an early sign of Reye Syndrome, a rare but serious condition.
Allergy Alert: Contains Salicylates. Do Not take if you are - allergic to salicylates (including aspirin) - taking other salicylate products.
Do not use if you have - blood or black stool - an ulcer - bleeding problem.
Ask a doctor before use if you are taking any drug for anti coagulation (thinning of the blood), diabetes,gout, arthritis. - When using this product a temporary but harmless darkening of the stool and/or tongue may occur.
Stop use and consult a doctor if - symptoms get worse - ringing in the ears or loss of hearing occurs - diarrhea lasts more that 2 days.
if pregnant or breast feeding
ask a professional before use. In case of accidental overdose, get medical help or contact a Poison Control Center immediately.
INACTIVE INGREDIENTS: CALCIUM HYDROXIDE, CITRIC ACID, ETHYL ALCOHOL, GLYCERINE, GUM ARABIC, OIL OF CINNAMON, OIL OF ORANGE, POTASSIUM CARBONATE, RHUBARB FLUID EXTRACT, SUGAR, PURIFIED WATER
(shake well before using)
Adults and children 12 yrs and over : 2 teaspoonfuls every hour as needed , not to exceed 4 doses in 24 hours and not more than 2 days.
Children under 12: Consult a doctor.
Keep out of reach of children.
Relieves diarrhea, reduces number of bowel movements.
Helps firm stool.
Relieves nausea, heartburn, fullness due to overindulgence of food and drink.
=======================================================
PERCY MEDICINE
FOR DIARRHEA
MANUFACTURED FOR
MERRICK MEDICINE COMPANY
WACO, TEXAS 76703
info@percymedicine.net
1-254-753-3461
Carton Label
Bottle Label
res
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 616343 | bismuth subsalicylate 1050 MG in 10 mL Oral Suspension | PSN | 14 |
| 1233767 | Percy Medicine 1050 MG in 10 mL Oral Supension | PSN | 14 |
| 1233767 | bismuth subsalicylate 105 MG/ML Oral Suspension [Percy Medicine] | SBD | 14 |
| 616343 | bismuth subsalicylate 105 MG/ML Oral Suspension | SCD | 14 |
| 616343 | bismuth subsalicylate 1050 MG per 10 ML Oral Suspension | SY | 14 |
| 1233767 | Percy Medicine 105 MG/ML Oral Suspension | SY | 14 |
| 1233767 | Percy Medicine 1050 MG per 10 ML Oral Supension | SY | 14 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0322-2222-00 | Percy Medicine | 1 in 1 BOX | LIQUID | 1 | 14 | |
| 0322-2222-03 | Percy Medicine | 90 mL in 1 BOTTLE | LIQUID | 90 | 14 | |
| 0322-2222-04 | Percy Medicine | 118 mL in 1 BOTTLE | LIQUID | 118 | 14 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0322-2222-03 | ML - Milliliter | 0322-2222 | ae580ba7-40cf-48d2-ab3d-27cb4210aad5 | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BISMUTH SUBSALICYLATE | ACTIVE INGREDIENT | 62TEY51RR1 | 2 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 2 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| CALCIUM HYDROXIDE | INACTIVE INGREDIENT | PF5DZW74VN | 2 | |
| CINNAMON OIL | INACTIVE INGREDIENT | E5GY4I6YCZ | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| ORANGE OIL | INACTIVE INGREDIENT | AKN3KSD11B | 2 | |
| POTASSIUM CARBONATE | INACTIVE INGREDIENT | BQN1B9B9HA | 2 | |
| RHUBARB | INACTIVE INGREDIENT | G280W4MW6E | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0322-2222 | 0322-2222-03, 0322-2222-00, 0322-2222-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| CALCIUM HYDROXIDE | PF5DZW74VN | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ACACIA | 5C5403N26O | IACT |
| ORANGE OIL | AKN3KSD11B | IACT |
| CINNAMON OIL | E5GY4I6YCZ | IACT |
| POTASSIUM CARBONATE | BQN1B9B9HA | IACT |
| RHUBARB | G280W4MW6E | IACT |
| SUCROSE | C151H8M554 | IACT |
| BISMUTH SUBSALICYLATE | 62TEY51RR1 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 12 | 2025-07-21 | full-release | 2026-06-01 01:08:11 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | ELIXIR / ORAL | 0.58 mg/5ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ORANGE OIL | ORANGE OIL, COLD PRESSED | AKN3KSD11B | LIQUID / ORAL | 50 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | SOLUTION / ORAL | 6.2 mg/1ml | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| ACACIA | ACACIA | 5C5403N26O | LOZENGE / ORAL | 108 mg | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | SUSPENSION / ORAL | 0.2 mg/5ml | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SOLUTION / ORAL | NA | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | ELIXIR / ORAL | 0.58 mg/5ml | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | SYRUP / ORAL | 0.05 mg/5ml | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | SOLUTION / ORAL | 6.2 mg/1ml | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, EXTENDED RELEASE / ORAL | 34.4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SUSPENSION / ORAL | 2 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER / ORAL | 800 mg | ||
| ACACIA | ACACIA | 5C5403N26O | LOZENGE / ORAL | 108 mg | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | PASTILLE / ORAL | 4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | LOZENGE / ORAL | 108 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | PASTILLE / ORAL | 4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER / ORAL | 800 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, CHEWABLE / ORAL | 121 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SUSPENSION / ORAL | 7386 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | CAPSULE / ORAL | 27.69 mg | ||
| ACACIA | ACACIA | 5C5403N26O | CAPSULE / ORAL | 20 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | TABLET / ORAL | 120 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SUSPENSION / ORAL | 2 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | SYRUP / ORAL | 0.05 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, EXTENDED RELEASE / ORAL | 34.4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | SOLUTION / ORAL | 6.2 mg/1ml | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SUSPENSION / ORAL | 7386 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | SOLUTION / ORAL | 6.2 mg/1ml | ||
| CINNAMON OIL | CINNAMON OIL | E5GY4I6YCZ | SUSPENSION / ORAL | 0.2 mg/5ml | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, COATED / ORAL | 156 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, EXTENDED RELEASE / ORAL | 34.4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| POTASSIUM CARBONATE | POTASSIUM CARBONATE | BQN1B9B9HA | CAPSULE / ORAL | 27.69 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SOLUTION / ORAL | NA | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| ACACIA | ACACIA | 5C5403N26O | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Percy Medicine | BISMUTH SUBSALICYLATE | Merrick Medicine Company, Inc | 08dd53b7-8345-4849-9155-60429cbe2c51 | 2025-11-11 | Warnings | 0322-2222-04 0322-2222-03 0322-2222-00 0322-2222 00322222203 00322222200 00322222204 920b3bd5-7ef1-43b7-a7ce-015b880f4b41 08dd53b7-8345-4849-9155-60429cbe2c51 |
Adverse event summaries are temporarily unavailable. Other product information remains available.